ANIXA BIOSCIENCES INC Total Assets 2010-2022 | ANIX

ANIXA BIOSCIENCES INC total assets from 2010 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
ANIXA BIOSCIENCES INC Annual Total Assets
(Millions of US $)
2021 $36
2020 $9
2019 $6
2018 $6
2017 $9
2016 $6
2015 $9
2014 $9
2013 $5
2012 $6
2011 $9
2010 $10
2009 $10
ANIXA BIOSCIENCES INC Quarterly Total Assets
(Millions of US $)
2022-01-31 $35
2021-10-31 $36
2021-07-31 $37
2021-04-30 $38
2021-01-31 $15
2020-10-31 $9
2020-07-31 $9
2020-04-30 $6
2020-01-31 $6
2019-10-31 $6
2019-07-31 $7
2019-04-30 $8
2019-01-31 $6
2018-10-31 $6
2018-07-31 $7
2018-04-30 $7
2018-01-31 $7
2017-10-31 $9
2017-07-31 $8
2017-04-30 $7
2017-01-31 $4
2016-10-31 $6
2016-07-31 $6
2016-04-30 $7
2016-01-31 $9
2015-10-31 $9
2015-07-31 $10
2015-04-30 $11
2015-01-31 $13
2014-10-31 $9
2014-07-31 $13
2014-04-30 $11
2014-01-31 $10
2013-10-31 $5
2013-07-31 $5
2013-04-30 $7
2013-01-31 $8
2012-10-31 $6
2012-07-31 $6
2012-04-30 $7
2012-01-31 $8
2011-10-31 $9
2011-07-31 $10
2011-04-30 $9
2011-01-31 $8
2010-10-31 $10
2010-07-31 $9
2010-04-30 $10
2010-01-31 $10
2009-10-31 $10
2009-07-31 $8
2009-04-30 $6
2009-01-31 $6
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.102B $0.001B
Anixa Biosciences, Inc. operates as a bio-technology company. It develops diagnostics and therapeutics to detect cancer. Anixa Biosciences Inc., formerly known as ITUS Corporation, is based in San Jose, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $161.383B 9.82
Bio-Rad Laboratories (BIO.B) United States $15.121B 32.79
QIAGEN (QGEN) Netherlands $10.475B 16.53
Biohaven Pharmaceutical Holding (BHVN) United States $9.944B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.681B 0.00
Emergent Biosolutions (EBS) United States $1.444B 6.18
Arcus Biosciences (RCUS) United States $1.389B 35.22
Myovant Sciences (MYOV) United Kingdom $0.879B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.509B 0.00
Gelesis Holdings (GLS) United States $0.362B 0.00
Zymeworks (ZYME) Canada $0.321B 0.00
Ambrx Biopharma (AMAM) United States $0.159B 0.00
Enzo Biochem (ENZ) United States $0.114B 23.50
SQZ Biotechnologies (SQZ) United States $0.093B 0.00